BRUKER CORPORATION Derivative Liability, Current
BRUKER CORPORATION (BRKR) had Derivative Liability, Current of $39.10 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2026-02-27
- 2025-12-31: Derivative Liability, Current $39.10M.
- 2024-12-31: Derivative Liability, Current $900.00K.
- 2023-12-31: Derivative Liability, Current $900.00K.
- 2022-12-31: Derivative Liability, Current $900.00K.
| Period end | Derivative Liability, Current |
|---|---|
| 2025-12-31 | $39.10M 10-K · filed 2026-02-27 |
| 2024-12-31 | $900.00K 10-K · filed 2026-02-27 |
| 2023-12-31 | $900.00K 10-K · filed 2024-02-29 |
| 2022-12-31 | $900.00K 10-K · filed 2024-02-29 |
| 2021-12-31 | $6.40M 10-K · filed 2023-03-01 |
| 2020-12-31 | $8.00M 10-K · filed 2022-02-28 |
| 2019-12-31 | $1.20M 10-K · filed 2021-03-01 |
| 2018-12-31 | $4.20M 10-K · filed 2020-03-27 |
| 2017-12-31 | $2.40M 10-K · filed 2019-03-01 |
| 2016-12-31 | $1.80M 10-K · filed 2018-03-16 |
| 2015-12-31 | $2.20M 10-K · filed 2017-03-01 |
| 2014-12-31 | $5.70M 10-K · filed 2016-02-29 |
| 2013-12-31 | $600.00K 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |